These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33907649)

  • 1. Influence of Framing: Recruitment to a Diabetes Disease Management Program From an Emergency Department Improves Enrollment and Outcomes.
    Moss R; Craige EK; Levine B; Mittal M; Ahn S; Appold B; Richman M
    Cureus; 2021 Mar; 13(3):e14116. PubMed ID: 33907649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the emergency department for less-urgent care among type 2 diabetics under a disease management program.
    Chiou SJ; Campbell C; Horswell R; Myers L; Culbertson R
    BMC Health Serv Res; 2009 Dec; 9():223. PubMed ID: 19968871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c testing in an emergency department.
    Magee MF; Nassar C
    J Diabetes Sci Technol; 2011 Nov; 5(6):1437-43. PubMed ID: 22226261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.
    Laxy M; Stark R; Meisinger C; Kirchberger I; Heier M; von Scheidt W; Holle R
    Diabetol Metab Syndr; 2015; 7():77. PubMed ID: 26388948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency department patients with diabetes have better glycemic control when they have identifiable primary care providers.
    Horwitz DA; Schwarz ES; Scott MG; Lewis LM
    Acad Emerg Med; 2012 Jun; 19(6):650-5. PubMed ID: 22632540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.
    Ostermann H; Hoess V; Mueller M
    BMC Public Health; 2012 Jun; 12():490. PubMed ID: 22742209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.
    Bestehorn K; Jannowitz C; Karmann B; Pittrow D; Kirch W
    BMC Public Health; 2009 Aug; 9():280. PubMed ID: 19653899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
    Edelman SV; Ermakova A; Xiong Y; Sieradzan R; Taylor SD
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1420-1431. PubMed ID: 31550190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.
    Röttger J; Blümel M; Busse R
    BMC Health Serv Res; 2017 Apr; 17(1):246. PubMed ID: 28372554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.